Info

Macular degeneration

Antineoplastic

Source: Compiled from Owens, Zambrowicz and Sands, Reichert, Brown, and Reichert and Paquette.

Table 10.2 Mean Clinical and FDA Approval Phases for Therapeutic Recombinant Proteins

A. For Various Therapeutic Indications

Interval

A. For Various Therapeutic Indications

Interval

Table 10.2 Mean Clinical and FDA Approval Phases for Therapeutic Recombinant Proteins

0 0

Post a comment